AYALA PHARMACEUTICALS, INC.: capex
| Value | {"amount": 3449000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2016-11-01 – 2017-10-31 |
| Status | current |
| Entity | AYALA PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:01:28.181425+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d3e05f54-2e6d-44ea-b073-813f2d7acf0c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001493152-19-000489 · Open the official SEC filing →Retrieved: 2026-08-19T11:01:28.181425+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001100397/capex/2017-10-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d3e05f54-2e6d-44ea-b073-813f2d7acf0c
History
- supersedes {"amount": 3449271, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001493152-17-014889)